Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.
Veronica Dell'AcquaAlessia SurgoSimona ArculeoMaria Alessia ZerellaVincenzo BagnardiSamuele FrassoniMaria Giulia ZampinoPaola Simona RavendaMaria Saveria RotundoFatjona KrajaJarek KobielaPiotr SpychalskiCristiana FodorMarianna Alessandra GerardiFederica CattaniAlessia BazaniWanda PetzRobert Glynne-JonesRoberto OrecchiaMaria Cristina LeonardiBarbara Alicja Jereczek-FossaPublished in: International journal of colorectal disease (2020)
Our study showed an excellent clinical result and very low acute toxicity rates, confirming the IMRT as standard of care for curative treatment of anal cancer patients. The current trial was registered with the number IEO N87/11.
Keyphrases
- squamous cell
- liver failure
- healthcare
- oxidative stress
- respiratory failure
- clinical trial
- early stage
- radiation therapy
- palliative care
- high grade
- randomized controlled trial
- drug induced
- aortic dissection
- quality improvement
- young adults
- radiation induced
- extracorporeal membrane oxygenation
- childhood cancer
- oxide nanoparticles